Autobio Diagnostics Co., Ltd.
603658.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.11B
Close$
$25.23
22.3% downside
Current Fair Value
22.3% downsideOvervalued by 22.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $19.11 Billion |
|---|---|
| Enterprise Value | $18.95 Billion |
| Dividend Yield | $1.31 (3.92%) |
| Earnings per Share | $1.87 |
| Beta | -0.02 |
| Outstanding Shares | 571,424,768 |
Return
| Return on Equity | 11.46% |
|---|---|
| Return on Assets | 8.43% |
| Return on Invested Capital | 10.65% |
Valuation & Multiples
| P/E Ratio | 19.34 |
|---|---|
| PEG | -143.96 |
| Price to Sales | 4.64 |
| Price to Book Ratio | 2.16 |
| Enterprise Value to Revenue | 4.49 |
| Enterprise Value to EBIT | 18.68 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.07 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.06 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Autobio Diagnostics Co., Ltd.
5,700 employees
CEO: Zeng Li Yang Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents ...